STRIDES PHARMA SCIENCE LIMITED — AGM Information 2020

Aug 20, 2020

August 20, 2020

The BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051. Scrip Code: STAR

Dear Sir,

Ref : 29[th] Annual General Meeting of the Company and disclosure under SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

We wish to inform you that the 29[th] Annual General Meeting (‘AGM’) of the Company was held today i.e., on Thursday, August 20, 2020.

In this connection, please find enclosed the summary of proceedings of the AGM as required under Regulation 30 of SEBI Listing Regulations.

This is for your information and records.

Thanks & Regards,

For Strides Pharma Science Limited

==> picture [114 x 46] intentionally omitted <==

Manjula Ramamurthy Company Secretary

==> picture [85 x 82] intentionally omitted <==

Encl. as above

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp Off : Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India Tel: +91 80 6784 0000 Fax: +91 80 6784 0700 Regd Off : 201, Devavrata, Sector 17, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924 / 3199 Fax: +91 22 2789 2942 info@strides.com; www.strides.com

SUMMARY OF PROCEEDINGS OF THE TWENTY-NINTH ANNUAL GENERAL MEETING OF THE COMPANY HELD ON THURSDAY, AUGUST 20, 2020 FROM 15:00 HRS TO 16:05 HRS THROUGH VIDEO CONFERENCE

Present:

Name	Designation	Attended through VC from
Mr. Arun Kumar	Founder & Non-Executive Chairperson	Corporate Office, Bangalore
Dr. R Ananthanarayanan	ManagingDirector & CEO
Mr. Badree Komandur	Executive Director,Finance & GroupCFO
Dr. Kausalya Santhanam	Independent Director and Chairperson of CSR Committee	Residence, Bangalore
Mr. Deepak Vaidya	Non-Executive Director & Chairperson of Stakeholder RelationshipCommittee	Residence, Mumbai
Mr. S. Sridhar	Independent Director and Chairperson of Audit Committee	Residence, Mumbai
Mr. Homi Khusrokhan	Independent Director and Chairperson of Risk Management Committee	Residence, Mumbai
Mr. Bharat Shah	Independent Director and Chairperson of Nomination and Remuneration Committee	Residence, London
Ms. Manjula Ramamurthy	Company Secretary	Corporate Office, Bangalore

In attendance:

Mr. Sampad Guha	Partner from B S R & Co. LLP, Chartered Accountants, Statutory Auditors of the Company	Residence, Bangalore
Mr. Bhanu Prakash	Partner from Grant Thornton India LLP, Internal Auditors of the Company	Residence, Bangalore
Mr. Gopalkrishnaraj HH	Proprietor, M/s. Gopalkrishnaraj HH & Associates, Company Secretaries, Secretarial Auditor of the Company	Residence, Bangalore
Mr. Binoy Chacko	Partner, M/s. Joseph and Chacko LLP; & Scrutinizer for the e-voting Process	Corporate Office, Bangalore

---

Company Secretary welcomed the Shareholders to the 29[th] Annual General Meeting (“AGM”) of the Company and introduced the Directors and other invitees present in the meeting to the Shareholders.

Mr. Arun Kumar, Founder & Non-Executive Director of the Company chaired the meeting.

As the requisite quorum was present, Meeting was called to order.

Shareholders were briefed about the arrangements made for the meeting.

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp Off : Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India Tel: +91 80 6784 0000 Fax: +91 80 6784 0700 Regd Off : 201, Devavrata, Sector 17, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924 / 3199 Fax: +91 22 2789 2942 info@strides.com; www.strides.com

It was informed that remote e-voting commenced on Sunday, August 16, 2020 and ended on Wednesday, August 19, 2020. Shareholders who had not cast their vote through remote e-voting, were requested to cast their vote in the course of the meeting through insta voting facility provided by Kfin by clicking on the “Vote” tab appearing on their screen.

With the consent of the Shareholders present, Notice convening the AGM was taken as read.

Shareholders were informed that:

• 1) Requisite Statutory Registers and other documents referred to in the Notice of AGM were available for inspection electronically by the Shareholders.

• 2) Certificate from Statutory Auditors of the Company, certifying that the existing ESOP Schemes of the Company have been implemented in accordance with the SEBI Regulation and in accordance with the Shareholders approval was also available for e-inspection.

• 3) Auditors Report for the Consolidated and Standalone statements of the Company for the financial year ended March 31, 2020 does not contain any qualification, observations or adverse comments.

Before proceeding with the businesses contained in the AGM Notice, Mr. Arun Kumar, Chairman of the Meeting, addressed the Shareholders attending the meeting through VC.

He then requested Dr. R Ananthanarayanan (Ananth) to provide his insights about the Company.

Ananth greeted the shareholders and made a brief presentation providing operational and financial highlights of the Company for the financial year ended March 31, 2020 and Q1 FY 21 performance and outlook.

Thereafter, Speaker Shareholders who had registered with the Company for speaking at the AGM were provided opportunity to express their views or ask their queries about the Company and the Agenda Items of the AGM.

Queries were jointly responded by Arun and Ananth.

Thereafter, the following items of business as mentioned in the Notice of the AGM dated May 20, 2020 were transacted at the meeting:

#	Resolutions Description	Type of
		Resolution
	Ordinary Business
1	Adoption of Audited Financial Statements for the FY ended March 31, 2020	Ordinary
2	Declaration of Final Dividend and confirmation of Interim Dividend for the FY ended March 31, 2020	Ordinary
3	Re-Appointment of Mr. Arun Kumar, retiring director, as a Non-Executive Director of the Company	Ordinary

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp Off : Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India Tel: +91 80 6784 0000 Fax: +91 80 6784 0700 Regd Off : 201, Devavrata, Sector 17, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924 / 3199 Fax: +91 22 2789 2942 info@strides.com; www.strides.com

	Special Business
4	Appointment of Dr. Kausalya Santhanam as an Independent Director of the Company	Ordinary
5	Appointment of Dr. R Ananthanarayanan as a Managing Director & Chief Executive Officer of the Company	Special
6	Re-appointment of Mr. Badree Komandur as an Executive Director- Finance & Group CFO of the Company	Special
7	Ratification of remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for FY 2019-20	Ordinary

Shareholders were requested to complete the evoting process, if not completed already. They were also were informed that Mr. Binoy Chacko, Scrutinizer of the evoting process, shall provide his report to the Company after the scrutiny of the votes casted by the Shareholders by remote e-voting and insta-voting. Company Secretary was authorised to declare the results of e-voting on or before Saturday, August 22, 2020.

Arun thanked the Shareholders and concluded the meeting.

For Strides Pharma Science Limited

==> picture [114 x 47] intentionally omitted <==

Manjula Ramamurthy Company Secretary

==> picture [85 x 83] intentionally omitted <==

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp Off : Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India Tel: +91 80 6784 0000 Fax: +91 80 6784 0700 Regd Off : 201, Devavrata, Sector 17, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924 / 3199 Fax: +91 22 2789 2942 info@strides.com; www.strides.com